{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:29:32Z","timestamp":1793644172393,"version":"4.5.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03816-9","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:08:09Z","timestamp":1741576089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prevalence of katG and inhA mutations associated with isoniazid resistance in Mycobacterium tuberculosis clinical isolates in Cameroon"],"prefix":"10.1186","volume":"25","author":[{"given":"Vanessa Ninkeh","family":"Nono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard Akono","family":"Nantia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awelani","family":"Mutshembele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorelle Nguimfack","family":"Teagho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick Willy Kamdem","family":"Simo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Shile","family":"Takong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne Josiane","family":"Djieugoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick Patrick","family":"Assolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne Magloire","family":"Ongboulal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley Nkemnji","family":"Awungafac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Eyangoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndivhuho Agnes","family":"Makhado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie Flore Donkeng","family":"Donfack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"3816_CR1","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/jam.14478","volume":"128","author":"R Singh","year":"2019","unstructured":"Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2019;128:1547\u201367. https:\/\/doi.org\/10.1111\/jam.14478.","journal-title":"J Appl Microbiol"},{"key":"3816_CR2","unstructured":"World Health Organization. Global tuberculosis report 2024. Blood. 2024. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/index.html."},{"key":"3816_CR3","unstructured":"World Health Organization. WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis. Geneva; 2018.\u00a0https:\/\/www.who.int\/publications\/i\/item\/9789241550079#."},{"key":"3816_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1003008","volume":"17","author":"AS Dean","year":"2020","unstructured":"Dean AS, Zignol M, Cabibbe AM, Falzon D, Glaziou P, Cirillo DM, et al. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: a multicountry analysis of cross-sectional data. PLoS Med. 2020;17:1\u201313. https:\/\/doi.org\/10.1371\/journal.pmed.1003008.","journal-title":"PLoS Med"},{"key":"3816_CR5","unstructured":"Sinthumule NP. Phenotypic and genotypic characterization of isoniazid resistance mutations in Mycobacterium tuberculosis isolates from new and previously treated patients in the Tshwane region. 2020. http:\/\/hdl.handle.net\/2263\/75519."},{"key":"3816_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12879-019-4333-4","volume":"19","author":"F Huo","year":"2019","unstructured":"Huo F, Lu J, Zong Z, Jing W, Shi J, Ma Y, et al. Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China. BMC Infect Dis. 2019;19:689. https:\/\/doi.org\/10.1186\/s12879-019-4333-4.","journal-title":"BMC Infect Dis"},{"key":"3816_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7759\/cureus.37136","volume":"15","author":"KP Ranjan","year":"2023","unstructured":"Ranjan KP, Ranjan N, Kumar N. Molecular characterization of katG and inhA mutations by genotype MTBDRplus line probe assay to guide isoniazid and ethionamide use for drug-resistant tuberculosis. Cureus. 2023;15:4\u201311. https:\/\/doi.org\/10.7759\/cureus.37136.","journal-title":"Cureus"},{"key":"3816_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol. 2016;45:474\u201392. https:\/\/doi.org\/10.1016\/j.meegid.2016.09.004.","journal-title":"Infect Genet Evol"},{"key":"3816_CR9","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1093\/jac\/dkv253","volume":"70","author":"T Jagielski","year":"2015","unstructured":"Jagielski T, Baku\u0142a Z, Roeske K, Kami\u0144ski M, Napi\u00f3rkowska A, Augustynowicz-Kope\u0107 E, et al. Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. J Antimicrob Chemother. 2015;70:3214\u201321. https:\/\/doi.org\/10.1093\/jac\/dkv253.","journal-title":"J Antimicrob Chemother"},{"key":"3816_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.00537-20","volume":"64","author":"E Narmandakh","year":"2020","unstructured":"Narmandakh E, Tumenbayar O, Borolzoi T, Erkhembayar B, Boldoo T, Dambaa N, et al. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis in Mongolia. Antimicrob Agents Chemother. 2020;64:1\u20137. https:\/\/doi.org\/10.1128\/AAC.00537-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"3816_CR11","first-page":"e95713","volume":"12","author":"X Cao","year":"2019","unstructured":"Cao X, Zhan Q, Guo Y, Yang J, Liu Y, Wan B, et al. Genotypic characterization of katG, inhA , and ahpC in isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Shanghai, China. Jundishapur J Microbiol. 2019;12:e95713 https:\/\/brieflands.com\/articles\/jjm-95713.pdf#.","journal-title":"Jundishapur J Microbiol"},{"key":"3816_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/IDR.S242261","volume":"13","author":"R Charoenpak","year":"2020","unstructured":"Charoenpak R, Santimaleeworagun W, Suwanpimolkul G, Manosuthi W, Kongsanan P, Petsong S, et al. Association between the phenotype and genotype of isoniazid resistance among Mycobacterium tuberculosis isolates in Thailand. Infect Drug Resist. 2020;13:627\u201334. https:\/\/doi.org\/10.2147\/IDR.S242261.","journal-title":"Infect Drug Resist"},{"key":"3816_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jmii.2013.08.018","volume":"48","author":"ST Tseng","year":"2015","unstructured":"Tseng ST, Tai CH, Li CR, Lin CF, Shi ZY. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan. J Microbiol Immunol Infect. 2015;48:249\u201355. https:\/\/doi.org\/10.1016\/j.jmii.2013.08.018.","journal-title":"J Microbiol Immunol Infect"},{"key":"3816_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.5588\/ijtld.14.0864","volume":"19","author":"A Asante-Poku","year":"2015","unstructured":"Asante-Poku A, Otchere ID, Danso E, Mensah DD, Bonsu F, Gagneux S, et al. Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana. Int J Tuberc Lung Dis. 2015;19:954\u20139. https:\/\/doi.org\/10.5588\/ijtld.14.0864.","journal-title":"Int J Tuberc Lung Dis."},{"key":"3816_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12941-021-00478-z","volume":"20","author":"M Ye","year":"2021","unstructured":"Ye M, Yuan W, Molaeipour L, Azizian K, Ahmadi A, Kouhsari E. Antibiotic heteroresistance in Mycobacterium tuberculosis isolates\u202f: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2021;20:73. https:\/\/doi.org\/10.1186\/s12941-021-00478-z.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"3816_CR16","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1128\/JCM.05793-11","volume":"50","author":"X Zhang","year":"2012","unstructured":"Zhang X, Zhao B, Liu L, Zhu Y, Zhao Y, Jin Q. Subpopulation analysis of heteroresistance to fluoroquinolone in Mycobacterium tuberculosis isolates from Beijing, China. J Clin Microbiol. 2012;50:1471\u20134. https:\/\/doi.org\/10.1128\/JCM.05793-11.","journal-title":"J Clin Microbiol"},{"key":"3816_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2489-3","volume":"17","author":"NN Abanda","year":"2017","unstructured":"Abanda NN, Djieugou\u00e9 JY, Lim E, Pefura-Yone EW, Mbacham WF, Vernet G, et al. Diagnostic accuracy and usefulness of the genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? A cross-sectional study. BMC Infect Dis. 2017;17:1\u201310 https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2489-3.","journal-title":"BMC Infect Dis"},{"key":"3816_CR18","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1128\/AAC.49.10.4068-4074.2005","volume":"49","author":"C Lavender","year":"2005","unstructured":"Lavender C, Globan M, Sievers A, Billman-jacobe H, Fyfe J. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob Agents Chemother. 2005;49:4068\u201374. https:\/\/doi.org\/10.1128\/AAC.49.10.4068-4074.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"3816_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0198091","volume":"13","author":"E Kigozi","year":"2018","unstructured":"Kigozi E, Kasule GW, Musisi K, Lukoye D, Kyobe S, Katabazi FA, et al. Prevalence and patterns of rifampicin and isoniazid resistance-conferring mutations in Mycobacterium tuberculosis isolates from Uganda. PLoS One. 2018;13:1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0198091.","journal-title":"PLoS One"},{"key":"3816_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12866-024-03256-x","volume":"24","author":"VFD Donfack","year":"2024","unstructured":"Donfack VFD, Fokou TAZ, Wadje LEN, Le Grand Napa Tchuedji Y, Djieugoue YJ, Nguimfack Teagho S, et al. Profile of non-tuberculous mycobacteria amongst tuberculosis presumptive people in Cameroon. BMC Microbiol. 2024;24:100. https:\/\/doi.org\/10.1186\/s12866-024-03256-x.","journal-title":"BMC Microbiol"},{"key":"3816_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jgar.2018.02.009","volume":"14","author":"C Alagappan","year":"2018","unstructured":"Alagappan C, Shivekar SS, Brammacharry U, Kapalamurthy VRC, Sakkaravarthy A, Subashkumar R, et al. Prevalence of mutations in genes associated with isoniazid resistance in Mycobacterium tuberculosis isolates from re-treated smear-positive pulmonary tuberculosis patients\u202f: a meta-analysis. J Glob Antimicrob Resist. 2018;14:253\u20139. https:\/\/doi.org\/10.1016\/j.jgar.2018.02.009.","journal-title":"J Glob Antimicrob Resist"},{"key":"3816_CR22","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1007\/s11033-022-07404-2","volume":"49","author":"P Bakhtiyariniya","year":"2022","unstructured":"Bakhtiyariniya P, Khosravi AD, Hashemzadeh M, Savari M. Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran. Mol Biol Rep. 2022;49:6135\u201343. https:\/\/doi.org\/10.1007\/s11033-022-07404-2.","journal-title":"Mol Biol Rep"},{"key":"3816_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.7196\/SAMJ.2019.v109i9.13730","volume":"109","author":"L Pitso","year":"2019","unstructured":"Pitso L, Chb MB, Medicine MI, Potgieter S, Chb MB, Medicine MI, et al. revalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa. S Afr Med J. 2019;109:659\u201364. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i9.13730.","journal-title":"S Afr Med J"},{"key":"3816_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bjid.2019.07.002","volume":"23","author":"GP Polu","year":"2019","unstructured":"Polu GP, Mohammad Shaik J, Kota NMK, Karumanchi D, Allam US. Analysis of drug resistance mutations in pulmonary Mycobacterium tuberculosis isolates in the Southern coastal region of Andhra Pradesh, India. Braz J Infect Dis. 2019;23:281\u201390. https:\/\/doi.org\/10.1016\/j.bjid.2019.07.002.","journal-title":"Braz J Infect Dis"},{"key":"3816_CR25","doi-asserted-by":"publisher","first-page":"MGM2\u20130014\u20132013","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","volume":"2","author":"C Vilch\u00e8ze","year":"2014","unstructured":"Vilch\u00e8ze C, Jacobs WR. Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities. Microbiol Spectr. 2014;2:MGM2-0014\u20132013. https:\/\/doi.org\/10.1128\/microbiolspec.MGM2-0014-2013.","journal-title":"Microbiol Spectr"},{"key":"3816_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/lungindia.lungindia_204_19","volume":"37","author":"AS Charan","year":"2020","unstructured":"Charan AS, Gupta N, Dixit R, Arora P, Patni T, Antony K, et al. Patterns of inhA and katG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates. Lung India. 2020;37:227\u201331. https:\/\/doi.org\/10.4103\/lungindia.lungindia_204_19.","journal-title":"Lung India"},{"key":"3816_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/idr15040041","volume":"15","author":"LM Faye","year":"2023","unstructured":"Faye LM, Hosu MC, Oostvogels S, Dippenaar A, Warren RM, Sineke N, et al. The detection of mutations and genotyping of drug-resistant Mycobacterium tuberculosis strains isolated from patients in the Rural Eastern Cape Province. Infect Dis Rep. 2023;15:403\u201316. https:\/\/doi.org\/10.3390\/idr15040041.","journal-title":"Infect Dis Rep"},{"key":"3816_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/Spectrum.00610-21","volume":"9","author":"HD Gliddon","year":"2021","unstructured":"Gliddon HD, Frampton D, Munsamy V, Heaney J, Pataillot-meakin T, Nastouli E, et al. A rapid drug resistance genotyping workflow for Mycobacterium tuberculosis, using targeted isothermal amplification and nanopore sequencing. Microbiol Spectr. 2021;9:9. https:\/\/doi.org\/10.1128\/Spectrum.00610-21.","journal-title":"Microbiol Spectr"},{"key":"3816_CR29","doi-asserted-by":"publisher","first-page":"e0119628","DOI":"10.1371\/journal.pone.0119628","volume":"10","author":"M Seifert","year":"2015","unstructured":"Seifert M, Catanzaro D, Catanzaro A, Rodwell TC. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS One. 2015;10:e0119628. https:\/\/doi.org\/10.1371\/journal.pone.0119628.","journal-title":"PLoS One"},{"key":"3816_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/thorax-2023-220202","volume":"79","author":"SN Danchuk","year":"2024","unstructured":"Danchuk SN, Solomon OE, Kohl TA, Dreyer V, Barilar I, Utpatel C, et al. Challenging the gold standard: the limitations of molecular assays for detection of Mycobacterium tuberculosis heteroresistance. Thorax. 2024;79:670\u20135. https:\/\/doi.org\/10.1136\/thorax-2023-220202.","journal-title":"Thorax."},{"key":"3816_CR31","doi-asserted-by":"publisher","first-page":"e02091","DOI":"10.1128\/AAC.02091-20","volume":"65","author":"SJ Valafar","year":"2021","unstructured":"Valafar SJ. Systematic review of mutations associated with isoniazid resistance points to continuing evolution and subsequent evasion of molecular detection, and potential for emergence of multidrug resistance in clinical strains of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2021;65:e02091\u2013120. https:\/\/doi.org\/10.1128\/AAC.02091-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"3816_CR32","doi-asserted-by":"publisher","unstructured":"Seid A, Kassa M, Girma Y, Dereb E, Nureddin S, Abebe A, et al. Molecular characterization of genetic mutations with fitness loss in pulmonary tuberculosis patients associated with HIV co-infection in Northwest Amhara, Ethiopia. SAGE Open Med. 2023;11. https:\/\/doi.org\/10.1177\/20503121231208266.","DOI":"10.1177\/20503121231208266"},{"key":"3816_CR33","doi-asserted-by":"publisher","first-page":"17552","DOI":"10.1038\/s41598-020-74432-y","volume":"10","author":"SS Shivekar","year":"2020","unstructured":"Shivekar SS, Kaliaperumal V, Brammacharry U, Sakkaravarthy A, Raj CKV, Alagappan C, et al. Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep. 2020;10:17552. https:\/\/doi.org\/10.1038\/s41598-020-74432-y.","journal-title":"Sci Rep"},{"key":"3816_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pulmoe.2018.03.004","volume":"24","author":"R Mar\u00e7\u00f4a","year":"2018","unstructured":"Mar\u00e7\u00f4a R. Tuberculosis and gender \u2013 factors influencing the risk of tuberculosis among men and women by age group. Pulmonology. 2018;24:199\u2013202. https:\/\/doi.org\/10.1016\/j.pulmoe.2018.03.004.","journal-title":"Pulmonology"},{"key":"3816_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0270003","volume":"17","author":"Y Xi","year":"2022","unstructured":"Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis. PLoS One. 2022;17:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0270003.","journal-title":"PLoS One"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03816-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:55:09Z","timestamp":1741618509000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3816"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03816-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was ethically approved by the Centre Regional Ethics Committee for Human Health Research in Cameroon (CRERSH-Ce) under approval number 00952\/CRERSHC\/2022.The study does not include any personal data. It utilized archived MTB clinical isolates routinely obtained from patients for diagnostic and therapeutic purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}